GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Ibnsina Pharma (CAI:ISPH) » Definitions » Days Sales Outstanding

Ibnsina Pharma (CAI:ISPH) Days Sales Outstanding : 86.44 (As of Jun. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Ibnsina Pharma Days Sales Outstanding?

Ibnsina Pharma's average Accounts Receivable for the three months ended in Jun. 2024 was E£11,593 Mil. Ibnsina Pharma's Revenue for the three months ended in Jun. 2024 was E£12,238 Mil. Hence, Ibnsina Pharma's Days Sales Outstanding for the three months ended in Jun. 2024 was 86.44.

The historical rank and industry rank for Ibnsina Pharma's Days Sales Outstanding or its related term are showing as below:

CAI:ISPH' s Days Sales Outstanding Range Over the Past 10 Years
Min: 83.34   Med: 88.88   Max: 94.42
Current: 86.27

During the past 9 years, Ibnsina Pharma's highest Days Sales Outstanding was 94.42. The lowest was 83.34. And the median was 88.88.

CAI:ISPH's Days Sales Outstanding is ranked worse than
68% of 100 companies
in the Medical Distribution industry
Industry Median: 72.49 vs CAI:ISPH: 86.27

Ibnsina Pharma's Days Sales Outstanding declined from Jun. 2023 (88.21) to Jun. 2024 (86.44).


Ibnsina Pharma Days Sales Outstanding Historical Data

The historical data trend for Ibnsina Pharma's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ibnsina Pharma Days Sales Outstanding Chart

Ibnsina Pharma Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only - - - 94.42 83.34

Ibnsina Pharma Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 88.21 84.06 85.15 89.13 86.44

Competitive Comparison of Ibnsina Pharma's Days Sales Outstanding

For the Medical Distribution subindustry, Ibnsina Pharma's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ibnsina Pharma's Days Sales Outstanding Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Ibnsina Pharma's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Ibnsina Pharma's Days Sales Outstanding falls into.



Ibnsina Pharma Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Ibnsina Pharma's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (5759.35 + 9743.889) / 2 ) / 33949.329*365
=7751.6195 / 33949.329*365
=83.34

Ibnsina Pharma's Days Sales Outstanding for the quarter that ended in Jun. 2024 is calculated as:

Days Sales Outstanding (Q: Jun. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Mar. 2024 ) + Accounts Receivable (A: Jun. 2024 )) / count ) / Revenue (A: Jun. 2024 )*Days in Period
=( (10912.838 + 12273.797) / 2 ) / 12237.828*365 / 4
=11593.3175 / 12237.828*365 / 4
=86.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ibnsina Pharma  (CAI:ISPH) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Ibnsina Pharma Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Ibnsina Pharma's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Ibnsina Pharma Business Description

Traded in Other Exchanges
N/A
Address
Industrial zone 1, PO box 91, Obour, EGY
Ibnsina Pharma is an Egypt based pharmaceutical distribution company. It is engaged in purchasing and selling in wholesale and distribution of pharmaceutical, semi- pharmaceutical and cosmetic products. It distributes a portfolio of pharmaceutical products from local and multinational pharmaceutical companies to retail pharmacies, wholesalers, hospitals, and public health institutions. In addition, the company also offers services including warehousing and logistics, marketing solutions, importation, and packaging, market research, and analysis.

Ibnsina Pharma Headlines

No Headlines